Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis

Authors:
  • RSRavit Saada
    Ravit Saada
  • RERaya Eilam
    Raya Eilam
  • LHLiat Hayardeny
    Liat Hayardeny
  • MSMichael Sela
    Michael Sela
  • RARuth Arnon
    Ruth Arnon

Abstract
No abstract available
Funding Information
  • Teva Pharmaceutical Industries (Israel)

This publication has 25 references indexed in Scilit: